• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

慢性阻塞性肺疾病的合并症及其对三级医疗医院患者住院情况的影响。

Comorbidities of Chronic Obstructive Pulmonary Disease and Their Affect on Hospitalization of Patients in a Tertiary Care Hospital.

作者信息

Sridhara Venkata Sai Hari Kalyan, Acharya Vishak

机构信息

Kasturba Medical College, Mangalore, Manipal Academy of Higher Education, Manipal, Mangalore, Karnataka,India.

出版信息

J Community Hosp Intern Med Perspect. 2021 Jan 26;11(1):120-123. doi: 10.1080/20009666.2020.1843823.

DOI:10.1080/20009666.2020.1843823
PMID:33552433
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7850373/
Abstract

: COPD is an obstructive airway disease with significant systemic comorbidities that affect hospitalization and the overall severity of the disease. The aim of the study was to assess the prevalence of comorbidities and their effect on the hospitalization of COPD patients. : The study was a cross-sectional study conducted in 2013 among patients of a tertiary care hospital. The sample size was 106. Inclusion criteria were diagnosed patients of COPD according to GOLD criteria. Patients were diagnosed with COPD based on GOLD criteria guidelines and evaluated for various comorbidities based on presenting complaints. Variables collected were the number and kind of diagnosed comorbidities, the average number of hospitalizations per year. The prevalence of each comorbidity was found out and the chi-square test (p < 0.05) was used to find out the correlation between hospitalization and comorbidities. : Of 106 participants, 63.2% had at least 1 comorbidity. 37.73% had 2-4 comorbidities. Prevalence of diabetes mellitus was 35.8%, systemic hypertension was diagnosed in 47% of the subjects. 5.7% had left heart abnormalities, 4.7% had ischemic heart disease (IHD), and 16% had pulmonary arterial hypertension. 43.4% had gastroesophageal reflux disease and gastric ulceration, 38.6% had metabolic syndrome and 8.5% had obstructive sleep apnea, 8% had psychiatric disorders, 7.5% had osteoporosis, and 1.9% were diagnosed with lung malignancy. There was a significant association between mean hospitalizations and the presence of comorbidities (p < 0.05). Hospitalizations were majorly due to exacerbation of COPD. : Prevalence of comorbid conditions among COPD patients are concluded to be high with an adverse effect on the average number of hospitalizations per year.

摘要

慢性阻塞性肺疾病(COPD)是一种具有显著全身合并症的阻塞性气道疾病,这些合并症会影响住院情况和疾病的整体严重程度。本研究的目的是评估合并症的患病率及其对COPD患者住院情况的影响。:该研究是2013年在一家三级护理医院的患者中进行的横断面研究。样本量为106例。纳入标准是根据慢性阻塞性肺疾病全球倡议(GOLD)标准确诊的COPD患者。患者根据GOLD标准指南被诊断为COPD,并根据主诉评估各种合并症。收集的变量包括确诊合并症的数量和种类、每年的平均住院次数。计算每种合并症的患病率,并使用卡方检验(p<0.05)来确定住院与合并症之间的相关性。:在106名参与者中,63.2%至少有一种合并症。37.73%有2至4种合并症。糖尿病患病率为35.8%,47%的受试者被诊断为系统性高血压。5.7%有左心异常,4.7%有缺血性心脏病(IHD),16%有肺动脉高压。43.4%有胃食管反流病和胃溃疡,38.6%有代谢综合征,8.5%有阻塞性睡眠呼吸暂停,8%有精神障碍,7.5%有骨质疏松症,1.9%被诊断为肺癌。平均住院次数与合并症的存在之间存在显著关联(p<0.05)。住院主要是由于COPD急性加重。:得出结论,COPD患者中合并症的患病率很高,对每年的平均住院次数有不利影响。

相似文献

1
Comorbidities of Chronic Obstructive Pulmonary Disease and Their Affect on Hospitalization of Patients in a Tertiary Care Hospital.慢性阻塞性肺疾病的合并症及其对三级医疗医院患者住院情况的影响。
J Community Hosp Intern Med Perspect. 2021 Jan 26;11(1):120-123. doi: 10.1080/20009666.2020.1843823.
2
Prevalence of comorbidities in COPD patients by disease severity in a German population.德国人群中,COPD 患者的疾病严重程度与合并症的患病率。
Respir Med. 2017 Nov;132:132-138. doi: 10.1016/j.rmed.2017.10.007. Epub 2017 Oct 12.
3
Comorbidities in chronic obstructive pulmonary disease: Results of a national multicenter research project.慢性阻塞性肺疾病的合并症:一项全国多中心研究项目的结果
Adv Clin Exp Med. 2019 Mar;28(3):319-324. doi: 10.17219/acem/78024.
4
Comorbidities and health status in individuals with and without COPD in five Latin American cities: the PLATINO study.在五个拉丁美洲城市中,有和没有 COPD 的个体的合并症和健康状况:PLATINO 研究。
Arch Bronconeumol. 2013 Nov;49(11):468-74. doi: 10.1016/j.arbres.2013.05.003. Epub 2013 Jul 13.
5
Prevalence of comorbidities according to predominant phenotype and severity of chronic obstructive pulmonary disease.根据慢性阻塞性肺疾病的主要表型和严重程度划分的合并症患病率。
Int J Chron Obstruct Pulmon Dis. 2016 Sep 14;11:2229-2236. doi: 10.2147/COPD.S111724. eCollection 2016.
6
[Risk assessment for sleep apnea syndrome and excessive daytime sleepiness in patients with chronic obstructive pulmonary disease].[慢性阻塞性肺疾病患者睡眠呼吸暂停综合征及日间过度嗜睡的风险评估]
Acta Med Croatica. 2013 Jun;67(3):219-24.
7
[Mortality and comorbidity in hospitalized chronic obstructive pulmonary disease patients].[住院慢性阻塞性肺疾病患者的死亡率和合并症]
Pneumonol Alergol Pol. 2011;79(5):343-6.
8
Prevalence of different comorbidities in COPD patients by gender and GOLD stage.慢性阻塞性肺疾病(COPD)患者中不同合并症按性别和全球慢性阻塞性肺疾病倡议(GOLD)分级的患病率
Multidiscip Respir Med. 2015 Aug 5;10(1):24. doi: 10.1186/s40248-015-0023-2. eCollection 2015.
9
Impact of comorbid conditions in COPD patients on health care resource utilization and costs in a predominantly Medicare population.慢性阻塞性肺疾病(COPD)患者的合并症对以医疗保险人群为主的医疗资源利用和成本的影响。
Int J Chron Obstruct Pulmon Dis. 2017 Feb 23;12:735-744. doi: 10.2147/COPD.S112256. eCollection 2017.
10
Outcomes in patients with chronic obstructive pulmonary disease and obstructive sleep apnea: the overlap syndrome.慢性阻塞性肺疾病和阻塞性睡眠呼吸暂停患者的结局:重叠综合征。
Am J Respir Crit Care Med. 2010 Aug 1;182(3):325-31. doi: 10.1164/rccm.200912-1869OC. Epub 2010 Apr 8.

引用本文的文献

1
Prevalence of pulmonary hypertension and its associated factors among chronic obstructive pulmonary diseases patients at public hospitals of Addis Ababa, Ethiopia, 2024: a facility-based cross-sectional study.2024年埃塞俄比亚亚的斯亚贝巴公立医院慢性阻塞性肺疾病患者肺动脉高压的患病率及其相关因素:一项基于机构的横断面研究
Front Public Health. 2024 Nov 26;12:1456235. doi: 10.3389/fpubh.2024.1456235. eCollection 2024.
2
Association of Phosphodiesterase-5 Inhibitor Treatment With Improved Survival in Pulmonary Hypertension Associated With COPD in the Pulmonary Vascular Research Institute GoDeep Meta-Registry.在肺血管研究所GoDeep荟萃登记处中,磷酸二酯酶-5抑制剂治疗与慢性阻塞性肺疾病相关肺动脉高压患者生存率提高之间的关联。
Chest. 2025 Jan;167(1):224-240. doi: 10.1016/j.chest.2024.08.016. Epub 2024 Sep 7.
3
The Incidence and Prevalence of Pulmonary Hypertension in the COPD Population: A Systematic Review and Meta-Analysis.COPD 人群中肺动脉高压的发病率和患病率:系统评价和荟萃分析。
Int J Chron Obstruct Pulmon Dis. 2022 Jun 10;17:1365-1379. doi: 10.2147/COPD.S359873. eCollection 2022.
4
Characteristics of length of stay and cardiovascular pharmacotherapy advice among chronic obstructive pulmonary disease patients.慢性阻塞性肺疾病患者的住院时间特征和心血管药物治疗建议。
Sci Prog. 2021 Oct;104(4):368504211066003. doi: 10.1177/00368504211066003.

本文引用的文献

1
2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT).2015年欧洲心脏病学会(ESC)/欧洲呼吸学会(ERS)肺动脉高压诊断和治疗指南:欧洲心脏病学会(ESC)和欧洲呼吸学会(ERS)肺动脉高压诊断和治疗联合工作组:得到以下组织认可:欧洲儿科和先天性心脏病协会(AEPC)、国际心肺移植学会(ISHLT)。
Eur Heart J. 2016 Jan 1;37(1):67-119. doi: 10.1093/eurheartj/ehv317. Epub 2015 Aug 29.
2
Anemia in Chronic obstructive pulmonary disease: Prevalence, pathogenesis, and potential impact.慢性阻塞性肺疾病中的贫血:患病率、发病机制及潜在影响
Lung India. 2015 Mar-Apr;32(2):142-51. doi: 10.4103/0970-2113.152626.
3
Comorbidities of COPD.COPD 的合并症。
Eur Respir Rev. 2013 Dec;22(130):454-75. doi: 10.1183/09059180.00008612.
4
INDACO project: a pilot study on incidence of comorbidities in COPD patients referred to pneumology units.因达科项目:一项针对转诊至呼吸科的慢性阻塞性肺疾病(COPD)患者共病发生率的试点研究。
Multidiscip Respir Med. 2013 Apr 3;8(1):28. doi: 10.1186/2049-6958-8-28.
5
Echocardiographic abnormalities in patients with COPD at their first hospital admission.慢性阻塞性肺疾病患者首次住院时的超声心动图异常。
Eur Respir J. 2013 Apr;41(4):784-91. doi: 10.1183/09031936.00222511. Epub 2012 Sep 27.
6
Chronic obstructive pulmonary disease: Does gender really matter?慢性阻塞性肺疾病:性别真的有影响吗?
Lung India. 2011 Oct;28(4):258-62. doi: 10.4103/0970-2113.85686.
7
Extrapulmonary comorbidities in chronic obstructive pulmonary disease: state of the art.慢性阻塞性肺疾病的肺外合并症:最新进展。
Expert Rev Respir Med. 2011 Oct;5(5):647-62. doi: 10.1586/ers.11.62.
8
Prevalence of comorbidities in patients with chronic obstructive pulmonary disease.慢性阻塞性肺疾病患者的合并症患病率。
Respiration. 2010;80(2):112-9. doi: 10.1159/000281880. Epub 2010 Feb 4.
9
Comorbidity, hospitalization, and mortality in COPD: results from a longitudinal study.COPD 中的合并症、住院和死亡率:一项纵向研究的结果。
Lung. 2010 Aug;188(4):321-9. doi: 10.1007/s00408-009-9222-y. Epub 2010 Jan 12.
10
Systemic manifestations and comorbidities of COPD.慢性阻塞性肺疾病的全身表现及合并症
Eur Respir J. 2009 May;33(5):1165-85. doi: 10.1183/09031936.00128008.